Arylsulfatase B Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Arylsulfatase B (ARSB) is a lysosomal hydrolase enzyme that catalyzes the removal of sulfate groups from glycosaminoglycans (GAGs), specifically dermatan sulfate and chondroitin sulfate. This enzyme is essential for the normal degradation and recycling of these complex carbohydrates within lysosomes.
Structure
Domain Architecture
Signal Peptide: 21 amino acids for ER targeting
Propeptide: 24 amino acids removed during processing
Sulfatase Domain: ~400 amino acids containing the catalytic site
Formylglycine Cofactor: Unusual post-translational modification essential for catalytic activity
...
Arylsulfatase B Protein
Introduction
Arylsulfatase B Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Arylsulfatase B (ARSB) is a lysosomal hydrolase enzyme that catalyzes the removal of sulfate groups from glycosaminoglycans (GAGs), specifically dermatan sulfate and chondroitin sulfate. This enzyme is essential for the normal degradation and recycling of these complex carbohydrates within lysosomes.
Structure
Domain Architecture
Signal Peptide: 21 amino acids for ER targeting
Propeptide: 24 amino acids removed during processing
Sulfatase Domain: ~400 amino acids containing the catalytic site
Formylglycine Cofactor: Unusual post-translational modification essential for catalytic activity
Crystal Structure
The enzyme adopts a sulfatase fold characteristic of all sulfatases
Active site contains a conserved cysteine/formylglycine
Two N-glycosylation sites for proper folding and stability
Dimeric in the active form
Post-Translational Modifications
Formylglycine (FGly) Modification: Catalytic residue generated from a cysteine at position 51
N-linked Glycosylation: Multiple sites for carbohydrate attachment
Phosphorylation: Some regulatory phosphorylation sites identified
Normal Function
Enzymatic Activity
Catalyzes hydrolysis of sulfate ester bonds at the non-reducing end of GAGs
Specifically targets 4-sulfate groups on dermatan sulfate and chondroitin sulfate
Optimal activity at acidic pH (5.0-5.5) consistent with lysosomal environment
Requires metal ions (Ca²⁺) for structural stability
Role in GAG Catabolism
Final step in lysosomal degradation of dermatan sulfate
Completes the breakdown cascade initiated by other sulfatases
Prevents accumulation of partially degraded GAGs
Cellular Importance
Maintains lysosomal function and cellular homeostasis
Prevents accumulation of toxic GAG fragments
Essential for normal proteoglycan turnover
Role in Disease
Mucopolysaccharidosis Type VI (MPS VI)
Also known as Maroteaux-Lamy syndrome, MPS VI is caused by deficiency of Arylsulfatase B activity.
The study of Arylsulfatase B Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.